We have updated our Privacy Policy and Terms of Use for Eurasia Group and its affiliates, including GZERO Media, to clarify the types of data we collect, how we collect it, how we use data and with whom we share data. By using our website you consent to our Terms and Conditions and Privacy Policy, including the transfer of your personal data to the United States from your country of residence, and our use of cookies described in our Cookie Policy.
{{ subpage.title }}
How can the world build back better public health after COVID?
Every year, over ten million people globally die from high blood pressure, more than all infectious diseases combined. Dr. Tom Frieden, former director of the Centers for Disease Control, is tackling this massive problem in public health, among many others, as CEO of Resolve to Save Lives.
He told GZERO’s Tony Maciulis that ensuring easy access to three drugs — amlodipine for blood pressure, metformin for blood sugar, and atorvastatin for cholesterol — could save tens of millions of lives over the next quarter century for just a penny per pill.
It’s part of a set of goals Frieden calls the three Rs: Renaissance in public health, robust primary healthcare and resilient populations. But as the developing world takes on more and more public debt, where will the money come from?
See more from Global Stage.
"We need to invest in public health," says former CDC director, lessons that "we better learn"
If we've learned anything from COVID, former CDC chief Tom Frieden says it's that we need to invest a lot more in public health.
"We need a renaissance in our public health system. We need a robust primary care system. And we need resilient populations," he tells Ian Bremmer on GZERO World.
Without good primary care, we can't get detect outbreaks, diagnose, treat, or vaccinate properly. Resilient populations means those that can withstand the shock of a pandemic because, for instance, chronic diseases are under control.
Trust is also an issue — and that's why Frieden wants the CDC to stay in Atlanta, far away from the White House.
Watch the GZERO World episode: How depoliticizing the US health response will save lives (COVID isn't over)
COVID ain't over
We're not done with the pandemic — yet.
In the US, infections are up five-fold from a year ago, although both hospitalizations are down.
Although COVID will likely become endemic sometime this year in some parts of the world, the virus will still rage on everywhere else.
China's zero-COVID strategy is having a tremendous cost, while barely 17.4% of Africans are vaccinated. That bodes well for new variants.
Meanwhile, rich countries keep hoarding jabs, now also against monkeypox. Did we not learn anything after more than two years?
Watch the GZERO World episode: How depoliticizing the US health response will save lives (COVID isn't over)
- Top Risks 2022: We're done with the pandemic, but the pandemic ... ›
- Let's learn from COVID to prevent the next pandemic - GZERO Media ›
- Is omicron the best thing that's happened since the pandemic started ... ›
- How depoliticizing the US health response will save lives (COVID ... ›
- Silicon Valley Bank Collapse: Not 2008 all over again - GZERO Media ›
"Stunningly infectious" COVID demands better preparation, says Former CDC director
Many people are done with the pandemic, but the pandemic ain't done with us yet.
Why? There's long COVID, and also we can't predict how the virus will play out in the future, former CDC chief Tom Frieden tells Ian Bremmer on GZERO World.
Still, he points out, the best way to "keep yourself out of the hospital and, quite frankly, out of the morgue" is to get vaxxed and boosted.
Frieden says he's stunned by how infectious COVID is compared to other diseases — and that's why those who claim they can predict what's going to happen in a few weeks don't know what they're talking about.
Watch the GZERO World episode: How depoliticizing the US health response will save lives (COVID isn't over)
How depoliticizing the US health response will save lives (COVID isn't over)
We're not done with the pandemic — yet.
Although COVID will likely become endemic sometime this year in some parts of the world, the virus will still rage on everywhere else.
On GZERO World, Ian Bremmer catches up on the pandemic's state of play with former CDC chief Tom Frieden, who has a message for everyone who hasn't gotten vaxxed yet: do it.
Why? New variants could emerge, making the virus more deadly.
Frieden also shares his thoughts on why China needs to transition to "almost" zero-COVID, the post-pandemic need to invest more in public health, and whether we should worry about monkeypox.
Bonus: we mark Pride month by looking at the history of the AIDS quilt.
- What we learned from COVID - GZERO Media ›
- Top Risks 2022: We're done with the pandemic, but the pandemic ... ›
- Should we worry about monkeypox? - GZERO Media ›
- Let's learn from COVID to prevent the next pandemic - GZERO Media ›
- China isn't budging on zero-COVID - GZERO Media ›
- Coming soon: the State of the World with Ian Bremmer - GZERO Media ›
- Coming soon: Ian Bremmer gives his 2022 update on the State of the World - GZERO Media ›
Episode 2: Saving the world’s water supply
Listen: Nearly half of the world's population currently lives in areas that face water scarcity for at least one month out of every year, and more than 1.2 billion people lack access to clean drinking water. This basic human need is too often at risk for communities around the globe, creating grave public health and security crises.
The latest episode of Living Beyond Borders, a special podcast series from GZERO brought to you by Citi Private Bank, examines the growing problem of both physical and economic water scarcity, and its potential to cause further humanitarian and security threats. Moderated by Mikaela McQuade, Director of Energy, Climate, and Resources at Eurasia Group, this episode features Harlin Singh, Global Head of Sustainable Investing at Citi Global Wealth, and Franck Gbaguidi, Senior Analyst of Energy, Climate, & Resources at Eurasia Group.
Mikaela McQuade
Director of Energy, Climate, and Resources at Eurasia Group
Harlin Singh
Global Head of Sustainable Investing at Citi Global Wealth
Franck Gbaguidi
Senior Analyst of Energy, Climate, & Resources at Eurasia Group
- S5 Episode 7: Future-proofing: How we fix broken supply chains - GZERO Media ›
- S3 Episode 7: Future-proofing: How we fix broken supply chains - GZERO Media ›
- S3 Episode 5: Could today’s crisis lead to future growth? - GZERO Media ›
- S3 Episode 9: US/China power struggle, the global political balance, and your finances - GZERO Media ›
- S3 Episode 6: Economic weapons & fallout of the new Cold War - GZERO Media ›
Can the world learn lessons from vaccine inequity?
GZERO Media and the Bill & Melinda Gates Foundation convened leading experts in public health, research, development, and philanthropy on Thursday to discuss the uneven state of global recovery from health and economic perspectives. Participants included moderator Natasha Kimani of Africa No Filter; Eurasia Group President Ian Bremmer; José Manuel Barroso, chair of Gavi, The Vaccine Alliance; Dr. John Nkengasong, director of the Africa Centers for Disease Control; Melanie Saville, director of vaccine research and development for CEPI; and Mark Suzman, CEO of The Bill & Melinda Gates Foundation.They discussed vaccine equity and how we can end the COVID pandemic in a way that better equips the world for similar challenges in the future.
On many streets in the UK and US, it’s almost possible to forget that there’s an ongoing COVID-19 pandemic. With so many westerners double vaccinated and boosted, the threat of the omicron variant has eased. In fact, the CDC just lifted mask recommendations for much of the US. But that doesn’t mean the pandemic is over. For many countries, that’s far from the case.
Moderator Natasha Kimani, the research and media programs lead at Africa No Filter, kicked off the discussion by asking where things stand today as the world marks the second anniversary of the pandemic.
“It depends on where you sit,” says Dr. John N. Nkengasong, a virologist and director of Africa’s CDC. “If you’re sitting in Africa, the glass is half empty. If you’re sitting in the global north, the glass may be half full.”
There’s a reason for optimism in parts of the world that have managed to vaccinate a majority of their populations. But in Africa, says Nkengasong, there’s deep concern because the virus, and its effects remain “very unpredictable and very unsettled.” Optimism elsewhere, he warns, should be approached with caution and humility because more surprises may await us. “There’s still a lot we need to learn about the virus,” he says.
Nkengasong is optimistic the world will overcome the pandemic but is concerned by how long it will take. “We are dealing with a very determined enemy — let there not be doubt in anyone’s mind.”
Sadly, many low-income countries are still struggling to get vaccines and distribute them properly. With only 11 percent of the African continent vaccinated, according to the UN, much more needs to be done.
So, why have some countries fared so well while others have languished?
“The world has not provided equitable distribution,” says Mark Suzman, CEO of The Bill & Melinda Gates Foundation, which came at the cost of “lives lost that could’ve been saved.” Before a vaccine was available, countries agreed in principle to distribute a future jab to the most vulnerable. But once a vaccine was developed, Suzman explains, domestic political pressures in western countries led to a free-for-all instead.
Politics aside, the production of such a quick and effective vaccine is remarkable, and the technological innovation is worth heralding. “I think we've put 10 years of development into less than a year,” says Melanie Saville, director of vaccine research and development for CEPI.
But as for the lessons to be learned from their unequal distribution? Suzman points to two areas. First, we must finish addressing the current crisis and ensure effective delivery of vaccines to the unvaccinated. But, second, we must get ahead of future health threats by ensuring there’s enough volume of treatments available in both low- and higher-income countries. To be ready for the next pandemic, he says, we need to have all the tools and structures in place, including good surveillance, research and development, and manufacturing capabilities to respond to health threats within a couple of hundred days.
You would think that a global pandemic threatening millions of lives would pull the world together in search of a solution. Instead, we’ve witnessed political fragmentation in the US and vaccine inequity worldwide.
Russia’s invasion of Ukraine, meanwhile, has managed to take the pandemic off everyone’s radar. What’s a deadly virus compared to the threat of nuclear weapons? “Maybe we should give President Putin a Nobel prize of medicine because, apparently, he made COVID disappear,” quips Manuel Barroso, chair of Gavi, The Vaccine Alliance. Putin, of course, did nothing of the sort, and low oxygen supplies in Ukraine have spotlighted how COVID, as well as many other medical issues, are amplified during times of war.
But the Russian assault on Ukraine has managed to breathe new life into transatlantic cooperation. Could this newfound energy for a bolstered alliance help move the needle on other issues, such as health?
“I think the answer’s yes,” says Eurasia Group President Ian Bremmer. The pandemic wasn’t enough to shake up the dysfunctions in geopolitics, he explains, pointing to the politicization of health care at home and vaccine distribution inequity worldwide.
But the idea of a western collision with a nuclear-armed Russia?
That’s enough to shake up the allies and get them moving forward together, and Bremmer expects that cooperation to be long-lasting and to extend beyond the realms of defense and security (the wildcard being China and its future relationship with Russia), which will hopefully make it easier to help end the COVID pandemic and prepare for future health crises.
Looking back at the fight against COVID, Nkengasong likens the struggle in 2020 to one of fighting “a war with bare hands.” Last year, vaccines became the main tool for fighting back. This year, he says, we need to use every tool at our disposal — including self-testing, vaccines, boosting vaccine equity worldwide, ensuring access to new drugs — to prepare for the next variant, which “might cause severe disease.”
Only then, in late 2022, does he think there’s hope for “seeing the light at the end of the tunnel.”
Omicron: What the latest Covid strain means for public health, economic recovery, and Joe Biden
We’re being told the ominous-sounding Omicron strain could have devastating consequences and take us back to the throes of March 2020. Or it could not. Maybe it’ll make things better rather than worse! But then again, maybe it won’t…
Really, there’s still an awful lot that we don’t know about this highly-mutated strain now running loose through every continent (except Antarctica, those lucky bastards).
You can watch my initial quick take on Omicron’s impact here (though things have changed a bit since I recorded that on Monday):
This has hurt his effectiveness in Congress, where Democrats are struggling to push his signature spending policies across the finish line. It is also jeopardizing Democrats’ already poor chances in next year’s midterm elections.
Biden has repeatedly said this pandemic is a pandemic of the unvaccinated and the result of President Trump’s “failure of leadership,” but the fact that Americans’ lives are still likely to be disrupted—with travel limited, conferences canceled, and service industries hindered—a year after he won an election on the promise of a “return to normalcy” will be a major headwind for him until this goes away.
Never mind that the federal government has few tools to stop the spread of the virus. Biden’s actions to date—a partial travel ban, new testing and vaccine requirements for travelers to the US, extending a mask mandate on transit, and offering to reimburse the cost of rapid test kits—demonstrate the limits of his powers. His most sweeping proposal, a vaccine or test mandate for large employers, is being challenged in the court and is engendering backlash against him among Republicans and some independents, whose approval ratings for Biden have dropped the most in recent months.
Absent a rapid positive resolution to the Omicron threat, the pandemic will weigh heavily on President Biden’s popularity.
🔔 And if you haven't already, don't forget to subscribe to my free newsletter, GZERO Daily by Ian Bremmer, to get new posts delivered to your inbox.